Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway-Reference-Cited by-同舟云学术

Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway

Published:2019-04-30 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Matte Isabelle,Garde-Granger Perrine,Bessette Paul,Piché Alain

Funder

Université de Sherbrooke

Centre de recherche CHUS

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5611-7.pdf

Reference45 articles.

1. Piché A. Pathobiological role of MUC16 mucin (CA125) of ovarian cancer: much more than a tumor biomarker. World J Obstet Gynecol. 2016;5:39–49.

2. Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371–5.

3. Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002;98:737–40.

4. O’Brien TJ, Beard JB, Underwood LJ, Shigemasa K. The CA125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol. 2002;23:154–69.

5. O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L. The CA125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol. 2001;22:348–66.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment;Future Pharmacology;2024-09-12

2. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08

3. Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer;Journal of Translational Medicine;2024-04-18

4. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites;Frontiers in Immunology;2024-04-05

5. Progress in the treatment of malignant ascites;Critical Reviews in Oncology/Hematology;2024-02